Jefferies Lowers PT On Albany Molecular Research To $4.50

February 8, 2011 8:00 AM | 8 seconds read |
Jefferies & Company has lowered the price target on Albany Molecular Research AMRI from $5.50 to $4.50 and maintains its Hold rating.
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Comments
Posted In: Price TargetAnalyst Ratingsalbany molecular researchHealth CareJefferies & CompanyLife Sciences Tools & Services
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!